Dry Eye Syndrome Treatment Market Overview, Analysis, Impact of Coronavirus (COVID-19) Pandemic
Dry Eye Syndrome Treatment People with autoimmune disorders or other systemic ailments such as diabetes, Parkinson's disease, rosacea, rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, Sjögren syndrome, and thyroid disease are at risk for dry eye syndrome. Furthermore, dry eyes might occur as a result of difficulties with inflammation of the eyelids (blepharitis) or the surfaces of the eye. Antihistamines, antidepressants, decongestants, and blood pressure drugs, among others, can lower tear production, resulting in dry eye symptoms. According to Coherent Market Insights, The global Dry Eye Syndrome Treatment Market is estimated to be valued at US$ 5,382.6 Million in 2020 and is expected to exhibit a CAGR of 16.2% during the forecast period (2020-2027). People who spend a lot of time in front of a computer or a screen are at a higher risk of having dry eyes, since prolonged usage of a screen reduces blinking and tear production. Due to widespread use for social